Venture Investment & Partnering (VIP) Forums
One of the WBBA’s objectives is to assist life science companies, entrepreneurs and researchers in bridging the gap between discovery and commercialization. To this end, WBBA has an exciting program called Venture Investment & Partnering (VIP) Forums. VIP Forums present a unique opportunity for local life science entrepreneurs, companies and researchers to meet with quality investors and strategic partners. We invite venture capital firms, corporate venture groups and multinational strategics (VIPs) to Seattle for a two-part event.
First, WBBA hosts a Plenary Session during which the VIP discusses their targets, interests, and investment/partnering strategies, and answers questions from the audience. The Plenary Session is followed by a networking reception. Second, pre-selected organizations present their investment and partnering opportunities to the VIP in a one-on-one setting.
Previous VIPs include LongTech Medical, Johnson & Johnson Development Corp.,Shire Pharmaceuticals, C.R. Bard, MedImmune Ventures and Partnering, H.I.G. BioVentures, Bristol-Myers Squibb, Bayer Healthcare, Merck Global Health Innovation, Takeda Ventures, Johnson & Johnson’s COSAT, BioWa, Inc., Essex Woodlands, NEA and OrbiMed.
Upcoming VIP Forums in 2014:
Eli Lilly and Company
April 15th-16th, 2014
Early consideration applications for One-on-One meetings due March 20th
VIP Forum with Eli Lilly and Company, featuring:
· Plenary Session Keynote with CEO John Lechleiter: Innovation for R&D Sustainability
· Networking Reception with the Eli Lilly external R&D and ventures team
· One-on-One meetings between selected WBBA-member organizations and the Eli Lilly team
The 10th largest pharmaceutical company in the world, Lilly has remained dedicated to creating medicines that help improve peoples' quality of life for more than 135 years. Companiesand researcherswith technologies in the areas listed below are encouraged to apply to meet one-on-one with Lilly executives. Follow the links to learn more about Lilly’s specific interests:
Register for the Plenary Session with Keynote by CEO John Lechleiter here.
There are no fees associated with this event; companies chosen for 1:1 meetings MUST be WBBA members.
VIP Forums are made possible by the partnership and generous support of:
If you have questions or are interested in visiting Seattle as a VIP or sponsoring VIP Forums, please contact email@example.com
Recent VIP Forums
December 5-6, 2013: Novo Nordisk
September 27-30 with LongTech Medical Technology
May 16-17: Johnson & Johnson Development Corp.
January 10: Bristol-Myers Squibb
December 5-6: Shire Pharmaceuticals
August 6-7: C.R. Bard
May 23-24, 2012: MedImmune Ventures & MedImmune Partnering
March 7-8, 2012: H.I.G. BioVentures